Parkinson's Disease Trial, Recruiting NCT07687979 Sponsor: Ege University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07687979
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease by a neurologist, based on clinical and imaging findings.
  • People whose Parkinson's disease falls between stages 1 and 3 on a standard scale used to measure how far the condition has progressed (the Modified Hoehn and Yahr Scale).
  • People who are able to walk at least 10 metres on their own, or with the help of a walking aid.
  • People who are in their medication's "ON" period — the time when Parkinson's medication is working and symptoms are better controlled.
  • People who are comfortable using technology such as a smartphone, as measured by a digital skills questionnaire (a score of 35 or higher on the Digital Competence Inventory for Older Adults).
  • People who can read, understand, and speak Turkish fluently.
  • People who are willing to take part in the study voluntarily.

Who may not be able to join:

  • People who have a neurological condition other than Parkinson's disease that affects how they move.
  • People who have had knee surgery or a significant knee injury in the past.
  • People who have had any surgery in the last 6 months.
  • People who have a deep brain stimulator device implanted.
  • People who have a hearing impairment.
  • People who have cognitive difficulties or are unable to understand and follow study instructions.
  • People who have other physical or health conditions that could affect walking assessments, such as limb amputation, severe diabetes, or alcohol dependency.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905056631833

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ege University
Registry
ClinicalTrials.gov
Start date
7 April 2026
Est. completion
1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Gait Speed; Timed Up and Go Test (TUG); Dual-Task Timed Up and Go Test; Freezing of Gait Questionnaire (FOGQ); Falls Efficacy Scale-International (FES-I); Five Times Sit to Stand Test (5xSST); Trunk Impairment Scale (TIS); System Usability Scale (SUS); Digital Competence Inventory for Older Adults

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov